STAAR receives approval certification to market Visian ICL with CentraFLOW in China

STAAR Surgical announced it has received approval certification from the China Food and Drug Administration to market Visian ICL with CentraFLOW technology in China, according to a company press release.The Visian ICL with CentraFLOW features a proprietary port in the center of the ICL optic that is designed to optimize the flow of fluid in the eye without affecting the patient’s quality of vision. Additionally, use of the CentraFLOW eliminates the need to perform a YAG peripheral iridotomy procedure within days of ICL implantation, according to the release.